Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia
Abstract Background Although the mononuclear cell (MNC) transplantation could theoretically induce therapeutic angiogenesis in the patients with no-option critical limb ischemia (NO-CLI), the clinical responses to this approach are inconsistent among different clinical trials. The purpose of this st...
Main Authors: | Tianyue Pan, Hao Liu, Yuan Fang, Zheng Wei, Shiyang Gu, Gang Fang, Yifan Liu, Yang Luo, Daqiao Guo, Xin Xu, Bin Chen, Junhao Jiang, Jue Yang, Zhenyu Shi, Ting Zhu, Yun Shi, Peng Liu, Zhihui Dong, Weiguo Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-018-1117-5 |
Similar Items
-
Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience
by: Gang Fang, et al.
Published: (2020-10-01) -
Exploring the Effects of Human Bone Marrow-Derived Mononuclear Cells on Angiogenesis In Vitro
by: Judith A. H. M. Peeters, et al.
Published: (2023-09-01) -
Bmal1 Downregulation Worsens Critical Limb Ischemia by Promoting Inflammation and Impairing Angiogenesis
by: Lirong Xu, et al.
Published: (2021-08-01) -
Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia
by: Xiaolang Jiang, et al.
Published: (2021-12-01) -
The promotion action of AURKA on post-ischemic angiogenesis in diabetes-related limb ischemia
by: Tao Bai, et al.
Published: (2023-03-01)